Allogeneic cell-mediated immunotherapy for eradication of minimal residual disease - an approach for successful cancer immunotherapy free from graft-versus-host disease (GVHD) using murine models

Author: Vourka-Karussis U.   Ackerstein A.   Pugatsch T.   Slavin S.  

Publisher: Elsevier

ISSN: 0301-472X

Source: Experimental Hematology, Vol.27, Iss.3, 1999-03, pp. : 461-469

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content